The foremost geopolitical rivalry between the US and China is increasingly being played out through trade and economic ...
The company points to “emerging research” that shows GLP-1RA medications offer benefits beyond weight loss for patients ...
In the complex and challenging field of early-phase clinical trials, logistics specialists are vital. A recent podcast spoke ...
Hemab Therapeutics has concluded an oversubscribed Series C funding round, raising $157m to further develop therapies for ...
MSD has received US FDA approval for an updated indication of Winrevair by injection to treat adults with pulmonary arterial ...
An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...
Norway's completed health tech assessments in 2025 were evaluated as positive, and raising thresholds may improve access conditions.
Fast growth for recently label-expanded drugs fuelled Novartis’ Q3 performance, despite headwinds from generic competition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback